CN102228616A - Chinese patent medicine for treating digestive system disease - Google Patents
Chinese patent medicine for treating digestive system disease Download PDFInfo
- Publication number
- CN102228616A CN102228616A CN 201110179236 CN201110179236A CN102228616A CN 102228616 A CN102228616 A CN 102228616A CN 201110179236 CN201110179236 CN 201110179236 CN 201110179236 A CN201110179236 A CN 201110179236A CN 102228616 A CN102228616 A CN 102228616A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese patent
- patent medicine
- radix
- digestive system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese patent medicine for treating a digestive system disease. The Chinese patent medicine for treating the digestive system disease comprises the following crude drugs in parts by weight: 3-40 parts of root of rehmannia, 3-15 parts of dwarf lilyturf root, 3-30 parts of root bark of the peony tree, 3-30 parts of figwort root, 3-30 parts of root of red-rooted salvia and 5-30 parts of dry hawthorn. The Chinese patent medicine for treating the digestive system disease is particularly suitable for treating symptoms such as constipation, gastrectasia and the like and has the advantages of definite therapeutic effect, safety, convenience and small side effect. Experience proves that the Chinese patent medicine has an excellent treatment effect on the digestive system disease, particularly the constipation, has the functions of invigorating the kidney and nourishing the blood and has an extremely obvious bowel relaxing effect; and the threat of the symptoms such as constipation and the like to the health of people can be obviously reduced.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese patent medicine for the treatment of digestive system disease.
Background technology
The common symptom of digestive system disease has dysphagia, nausea and vomiting, belch, pantothenic acid, inappetence, abdominal distention, stomachache, diarrhoea, constipation, abdominal mass, tenesmus, jaundice, hematemesis, melena, has blood in stool, nevus araneus of skin, supraclavicular lymph nodes enlargement etc.Common digestive system disease has esophagel disease, gastroesophageal reflux disease, chronic diarrhea, gastritis, hepatitis, liver cirrhosis, liver abscess, hepatocarcinoma, peptic ulcer, cholecystitis, cholelithiasis or the like.
Constipation in the digestive system disease is a kind of clinically commonly encountered diseases, frequently-occurring disease, according to statistics in the elderly population of over-65s sickness rate up to 25%.To be constipation reduce, lack just meaning, feces with patient's nature defecation frequency to constipation discharges difficulty or infrequent defecation overlong time or have that just to anticipate and can not arrange be feature, the lighter does not have significant discomfort, if the excrement piece is too hard, can cause hemorrhoid, stomachache, anal fissure, even the compressing sacral nerves.Because intestinal food debris, metabolite and toxin can not in time be discharged, and can cause slight toxemia, show as inappetence, feel sick, bitter taste, lethargy, dizzy weak, systemic pain, that continues causes anemia and malnutrition etc.Constipation is not only given people's orthobiosis and is brought inconvenience and misery, and because long-term difficult defecation can bring out and increase the weight of other diseases, for example apoplexy or myocardial infarction.Along with the quickening of China's aged tendency of population trend, habitual constipation has become a public health problem.
Because the multiple and hazardness of constipation, the foreign scholar pays much attention to the research to constipation.The international Rome II of in JIUYUE, 1999 coordination board on the basis of various countries experts and scholars to constipation research, a series of diagnostic criterias of having formulated Rome II functional gastrointestinal disease.Although the understanding of various countries' digestology bound pair constipation at present is not the same, but still based on the diagnostic criteria of Rome II, carries out all kinds of researchs.At present, at the treatment of constipation, the relevant speciality personage reaches common understanding in the world: promptly encourage to use short digestive tract power medicine treatment and non-drug therapy.Though yet short digestive tract power reinforcing medicine curative effect be firmly established, easily cause the generation of adverse events such as cardiovascular and cerebrovascular vessel, gerontal patient especially, this professional at home and abroad medical journals has a large amount of reports.Cisapride is as a kind of definite medicine of treatment constipation effect few in number, use comparatively extensive abroad, yet people such as Lacy BE, Appel S publish an article successively and point out recently, cisapride can delay the myocardial cell multipole, the QT interval, prolonged, may cause serious lethal ventricular arrhythmia, torsade de pointes.Biofeedback therapy also is the external a kind of no wound therapy of more popular treatment constipation at present, and to outlet obstructed type constipation satisfactory effect, particularly to coordination exercise obstacle constipation at the bottom of the basin, effective percentage reaches more than 90%, is subjected to the welcome of external constipation patient deeply.Faigel DO, Fank L etc. point out that biofeedback therapy is then not good enough to the chronic slow-transit constipation curative effect in the recent period, and are also relatively poor to neurogenic constipation curative effect.In a word, more abroad for the treatment research of constipation, but because or characteristics such as toxic and side effects is big or contraindication is many or indication is little, influenced clinical expansion to some extent.Therefore, the numerous scholars in various countries just actively carry out the research of Chinese medicine at present, and attempting with the Chinese medicine is point of penetration, seeks out the active drug of treatment primary disease.
At present, domestic patent documentation report about treatment digestive system disease medicine aspect is more, for example: 1, application number is 03137425.5, denomination of invention is the patent of invention of " a kind of medicine for the treatment of digestive system disease and preparation method thereof ", and the disclosed medicine of this patent of invention is the Chinese medicine made from medicines such as Radix Notoginseng, Rhizoma Corydalis, Rhizoma Cyperi, Fructus Evodiae, Concha Arcae, dried Alumen, Radix Glycyrrhizae, the Radix Paeoniae Alba, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Toosendan, magnesium oxide, sodium bicarbonate, Semen daturae fluid extracts.2, application number is 200910219362.9, denomination of invention is " a kind of Chinese patent medicine that is used for the treatment of digestive system disease ", the disclosed Chinese patent medicine of this patent of invention is made up of raw meat Herba Cistanches, Radix Angelicae Sinensis, Radix Scutellariae, Natrii Sulfas four flavor compositions, extracts and decocts extracting method through precipitate with ethanol and be prepared from.
Summary of the invention
The technical problem to be solved in the present invention provides a kind of Chinese patent medicine for the treatment of digestive system disease.The present invention treats the Chinese patent medicine of digestive system disease, particularly treats symptoms such as constipation, flatulence, and its determined curative effect, safe ready, side effect are little.Chinese patent medicine of the present invention is through facts have proved, to digestive system disease particularly constipation have good therapeutical effect, and have the function of kidney-replenishing blood-nourishing, the loosening bowel to relieve constipation effect is very obvious, can significantly reduce or eliminate the threat of constipation class disease to health of people.
In order to address the above problem, the technical solution used in the present invention is:
The invention provides a kind of Chinese patent medicine for the treatment of digestive system disease, represent, contain 3～40 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease with weight portion, 3～15 parts of Radix Ophiopogonis, 3～30 parts of Cortex Moutans, 3～30 parts of Radix Scrophulariaes, 5～30 parts of 3～30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, contain 3～15 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 3～8 parts of Radix Ophiopogonis, 3～10 parts of Cortex Moutans, 3～10 parts of Radix Scrophulariaes, 5～15 parts of 3～10 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, contain 15～30 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 8～15 parts of Radix Ophiopogonis, 10～20 parts of Cortex Moutans, 10～20 parts of Radix Scrophulariaes, 15～25 parts of 10～20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, contain 30～40 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 10～15 parts of Radix Ophiopogonis, 20～30 parts of Cortex Moutans, 20～30 parts of Radix Scrophulariaes, 25～30 parts of 20～30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, contain 3～15 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 3～8 parts of Radix Ophiopogonis, 3～10 parts of Cortex Moutans, 10～20 parts of Radix Scrophulariaes, 15～25 parts of 10～20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, contain 15～30 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 8～15 parts of Radix Ophiopogonis, 10～20 parts of Cortex Moutans, 20～30 parts of Radix Scrophulariaes, 25～30 parts of 20～30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, contain 30～40 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 10～15 parts of Radix Ophiopogonis, 20～30 parts of Cortex Moutans, 10～20 parts of Radix Scrophulariaes, 5～15 parts of 10～20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, contain 3～15 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 8～15 parts of Radix Ophiopogonis, 10～20 parts of Cortex Moutans, 20～30 parts of Radix Scrophulariaes, 10～20 parts of 15～25 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
Chinese patent medicine according to above-mentioned treatment digestive system disease, the preparation method of the Chinese patent medicine of described treatment digestive system disease is: the crude drug proportioning ratio according to the Chinese patent medicine of each described treatment digestive system disease of claim 1～8 takes by weighing various crude drug, various crude drug are pulverized filtration, obtain the medicated powder of various crude drug, medicated powder with its various crude drug after the pulverizing mixes, and packs behind the mix homogeneously to get final product.
According to the Chinese patent medicine of above-mentioned treatment digestive system disease, the dosage form of the Chinese patent medicine of described treatment digestive system disease is pharmaceutically acceptable dosage form.The dosage form that Chinese patent medicine of the present invention adopts usually is a powder.
Chinese patent medicine of the present invention also has certain curative effect to cardiovascular and cerebrovascular disease, for example utilizes Chinese patent medicine of the present invention can effectively treat symptoms such as hypertension, cerebral infarction, diabetes.
The pharmacological action of the various crude drug of the present invention:
The Radix Rehmanniae: sweet in the mouth, hardship, cold in nature; Go into the heart, liver, kidney three warps.Effect cures mainly: this product sweet-bitter flavor, cold in nature and go into blood system, clearing away heat and cooling blood.Cure mainly fever due to yin deficiency, quench one's thirst, spit blood, epistaxis, metrorrhagia, menoxenia, frequent fetal movement, the moon is hindered constipation.
The Radix Rehmanniae is the scrophulariaceae rehmannia glutinosa plant rhizome, sweet in the mouth and hardship, GUIXIN, liver, kidney channel have clearing away heat and cooling blood, yin nourishing, a function of promoting the production of body fluid, and are used for that calentura, crimson tongue excessive thirst tongue, interior-heat caused by deficiency of YIN, hectic fever due to YIN-deficiency are quenched one's thirst, haematemesis, menoxenia, frequent fetal movement, the moon hinder diseases such as constipation.
The sweet Han Zhirun of the Radix Rehmanniae, both kind removing heat from blood purges heat, kind again YIN nourishing and the production of body fluid promoting.All blood systems have heat and all dirty Tianjin impairment of YIN deficiency persons, are product commonly used.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature; GUIXIN, liver,kidney,spleen four warps.Effect cures mainly: the accent blood of 1, invigorating blood circulation: the Radix Salviae Miltiorrhizae red complexion, going into heart channel, bitter in the mouth can drop-down.So heart governing blood and vessels, blood stored in the liver are can promoting blood circulation to restore menstrual flow and transfer blood.This product can cure mainly menoxenia, amenorrhea due to stagnation of blood, metrorrhagia and metrostaxis, and disharmony of Chong and Conception Channels and frequent fetal movement, blood is more than down.Puerperal congestion, cards such as lochiorrhea.Because of its cold nature of this product, so stagnant person should it with heat in blood.The real key medicine of blood of transferring for invigorating blood circulation.2, stasis-dispelling and pain-killing: Radix Salviae Miltiorrhizae is the key medicine of blood system, goes into the heart, liver, kidney channel.If that the heart is become homeless is main, the liver blood meridians lose in catharsis, suffer from a deficiency of the kidney and by cold-damp the visitor, and the coagulation of QI-blood that causes; The strong foot numbness of spinal column, the card of pain, logical the loosing of this product energy removing blood stasis with potent drugs, the promoting the circulation of blood of invigorating blood circulation, congestion leads to and removes bitterly certainly.The Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, interiorization internal organs to the stasis of blood stagnates, but outer qualcomm meridian and sharp joint, so this product can cure mainly dysmenorrhea, puerperal the stasis of blood stomachache that stagnates, trusted subordinate's pain ， lumps in the chest and abdomen and the vexed obturation of wrist, hernia attack dash and end do free, foot knee joint numbness fistula and pain, or the joint that congestion is blocked is attacked congestion pain such as pain.Can disappear mass in the abdomen and removing mass is poly-, but migratory arthralgia work and strong waist knee joint again.It proves effective originally, all comes from blood circulation promoting and blood stasis dispelling, the merit of the logical operation of a surname.3, removing heat from blood detumescence: Radix Salviae Miltiorrhizae is gone into the heart, liver two warps, and its property is cold partially, so can removing heat from blood.But this product with promoting blood circulation and cooling blood be good at, dissipating blood stasis again.4, nourishing blood to tranquillize the mind: heart governing blood and vessels, main mind.This product event energy reinforcing the heart sedate, nourishing blood to tranquillize the mind, relieving restlessness can clear away heart-fire again.Both can treat the forgetful palpitation with a distress feeling due to the deficiency of heart-blood, the card of palpitation with fear uneasiness, and can treat calentura again and hinder and seek the card of dysphoria and insomnia.5, blood yiqi: the Radix Salviae Miltiorrhizae red complexion is gone into blood, can invigorate blood circulation, and can enrich blood again.This product reinforcement and elimination in combination is so there is the title of Zhiyang medicine in the moon.
Radix Scrophulariae: bitter in the mouth, sweet, salty, cold in nature; Go into lung, the heart, kidney three warps.Effect cures mainly: 1, heat-clearing and toxic substances removing: Radix Scrophulariae bitter in the mouth, sweet, salty, cold.Attack and arrogate to oneself heat clearing away, removing heat from blood, detoxifcation, pathogenic fire reducing.So heat syndrome that available a variety of causes causes.Can be used for treating cards such as cough due to lung-heat, drug-pedlar's nutrient blood, laryngopharynx swelling and pain, headache due to pathogenic wind-heat, the lung-heat difficulty in urination, stomach excessive heat.2, nourishing YIN to lower pathogenic fire: the property of Radix Scrophulariae tool official report Zhiyin, can move back pathogenic heat, sweet energy YIN nourishing, it is cold in nature, can coolly moisten nourishing kidney, and the merit victory is known, cypress, specially for the kidney monarch drug.Can be used for treating the lung yin loss, quench one's thirst, dysphoria and insomnia, fever due to yin deficiency, Tianjin are hindered constipation, puerperal card such as fever due to deficiency of blood, spontaneous perspiration, night sweat.3, eliminating stagnation eliminating carbuncle: Radix Scrophulariae is cool in nature, and flavor is hot again and little hardship is little salty slightly sweet, goes into cardiopulmonary kidney three warps, so can let out the fire that unrooted swims, tool rushes down the purgation merit on clearly.Also can profile satisfy in warp, and the carbuncle of the hot eliminating stagnation that disappears.Can be used for treating cards such as carbuncle sore tumefacting virus, scrofula sucutaneous nodule.
Cortex Moutan: the another name Cortex Moutan, acrid in the mouth, hardship, cool in nature; Go into the heart, liver, kidney three warps.Effect cures mainly: 1, clearing away heat and cooling blood: Cortex Moutan acrid in the mouth, hardship, cool in nature are the good medicine of clearing away heat and cooling blood.So be usually used in all cards of heat in blood.Can be used for treating heat and go into cards such as nutrient blood, infantile convulsion, headache due to pathogenic wind-heat, heat in blood are hemorrhage, osteopyrexia and fever.2, dissipating blood stasis and reducing the stagnation: Cortex Moutan acrid in the mouth hardship, cool in nature, Xin Nenghang can loose, and circulation of qi promoting promoting the circulation of blood, but hardship dampness expel the heat-evil, collateral dredging, but its cold heat clearing away again, so can be used for because of blood stasis the stagnation of QI and the card that causes a disease.Can be used for treating cards such as carbuncle, traumatic injury, blood stasis amenorrhea, lumps in the chest and abdomen, wind heat arthromyodynia.
Radix Ophiopogonis: the another name Radix Ophiopogonis, sweet in the mouth, little hardship, cold in nature; Go into lung, stomach, the heart three warps.Effect cures mainly: 1, nourishing YIN and moistening the lung: this product sweet in the mouth, and cold in nature, sweet cold tonifying YIN, the lunar lung meridian of starting with, merit is specially supported lung yin, and lung moistening is dry, is usually used in the pathogenic dryness impairing the lung, cards such as cough due to yin deficiency.2, clearing heat and relieving fidgetness: this product heat clearing away cold in nature, go into lung, stomach, heart channel, merit is arrogated to oneself resolving heat and reducing pathogenic fire, the tonify deficiency relieving restlessness, it is soft to can be used for the lung-heat fistula, cards such as cardiopulmonary deficiency-heat.3, reinforcing stomach reg fluid: the sweet Han Zhirun of this product, go into lung stomach warp, the good merchantable brand of reinforcing stomach reg fluid particularly, so can be quenching one's thirst that lung stomach Tianjin hinders, card such as constipation is used always.This product clearing away heat with drugs sweet in flavor and cold in nature, sweet cold tonifying YIN is gone into lung stomach warp, heat clearing away YIN nourishing, reinforcing stomach reg fluid, nourishing YIN and moistening the lung, real diabete key medicine for disappearing on controlling.This product nourishing the stomach to promote the production of body fluid, respectful lung intestine moistening, supplementing fluid to relax the bowels is body fluid deficiency constipation product commonly used.4, cooling blood for hemostasis: this product is cold in nature, returns lung stomach heart channel and goes into blood system, and hyperactivity of fire caused by deficiency of YIN is suitable in the function cooling blood for hemostasis, and absurd row of forcing blood and pathogenic dryness are hindered the haematemesis of network, cards such as knob blood and spitting of blood.
Fructus Crataegi: sour in the mouth, sweet, slightly warm in nature; Go into spleen, stomach, liver three warps.Effect cures mainly: 1, promoting digestion and removing stagnation: the Crataegolic acid temperature, the kind smelling of fish or mutton that disappears is greasy long-pending, is the medicine that digests, and is usually used in a little less than the food stagnation spleen cards such as gastral cavilty distension.Can be used for cards such as treatment is stagnant, gastral cavilty distending pain, the stomachache of pulling together.2, circulation of qi promoting dissipating blood stasis: the little acid gas of this product sweet in the mouth is flat, and congestion pain is gone in the stagnant circulation of qi promoting of being good at disappearing of its property.Be used for cards such as congestion amenorrhea, postpartum stagnation, trusted subordinate's twinge, hernia pain.
Positive beneficial effect of the present invention:
1, to treat the Chinese patent medicine raw material prescription element of digestive system disease few in the present invention, and the collocation science has no side effect, for digestive system disease particularly constipation have significant curative effect; And the dim complexion that digestive system disease is caused or see that the pigmentation disease has certain curative effect.
2, utilize Drug therapy digestive system disease, particularly constipation of the present invention, its short treating period, expense are low, and therapeutic effect is remarkable.
3, utilize Drug therapy digestive system disease of the present invention, effect is remarkable, and total effective rate reaches more than 90%, and cure rate reaches more than 80%.
Utilize Chinese patent drugs for treatment digestive system disease patient's of the present invention clinical data:
In recent years, utilized nearly 260 examples of Chinese patent drugs for treatment digestive system disease patient of the present invention, women patient's 150 examples, male patient's 110 examples, digestive system disease patient's age section is 35～80 years old.
Therapeutic Method: the patient different according to symptom, utilize prescription of the present invention to allocate, be ground into fine powder then, mix homogeneously is packaged into powder, every bag of 15g during the powder packing.Take after mixing it with hot water when taking.
Observation of curative effect:
Criterion of therapeutical effect: cure: various malaise symptoms disappear, and all recover normal; Effectively: various symptoms are most of to disappear, and still has relevant uncomfortable; Invalid: various symptoms do not have any improvement.
Therapeutic effect:
Utilize the present invention to treat the Chinese patent drugs for treatment 260 routine patients of digestive system disease, wherein cure 226 many cases, effective 28 examples, invalid 6 examples, total effective rate reaches 97%, and cure rate reaches 87%, and what healing patient's time was the shortest is 5 days.
Model case:
1, Zhang, man 41 years old, people from Zhengzhou City is diagnosed as constipation through Zhengzhou First People Hospital in October, 2008, patient oral account: less, the dyschesia of times of defecation, and cause malaise symptoms such as abdominal distention.Come here to go to a doctor upon somebody's introduction, take the Chinese herbal medicine powder that the present invention treats digestive system disease (one day one bag, every bag 15 gram takes after mixing it with hot water and takes; This patient adopts the crude drug proportioning of Chinese patent medicine of the present invention referring to embodiment 1), take physogastry disappearance after 7 days continuously, stool is normal, the basic recovery normally.In April, 2009, all were normal by examination in hospital.
2, Lee so-and-so, the man, 36 years old, people from Xinxiang City checked by Zhengzhou No.3 People's Hospital in October, 2007, is diagnosed as hypertension, constipation, patient oral account: dyschesia, about three days once, abdominal distention, dizziness, inappetence.Come here to go to a doctor upon somebody's introduction, take the Chinese herbal medicine powder that the present invention treats digestive system disease (one day one bag, every bag 15 gram takes after mixing it with hot water and takes; This patient adopts the crude drug proportioning of Chinese patent medicine of the present invention referring to embodiment 5), take 12 days continuously after, abdominal distention, dizzy phenomenon disappear, stool is normal, recovers normal substantially.By examination in hospital, all are normal after half a year.
3, Liu, woman 52 years old, people from Xinzheng City is diagnosed as intestinal obstruction in local hospital, done the proctoptosis operation in March, 2005, and in April, 2010, disease relapse goes to operation for the second time.After come here to go to a doctor upon somebody's introduction, take the Chinese herbal medicine powder that the present invention treats digestive system disease (one day one bag, every bag 15 gram takes after mixing it with hot water and takes; This patient adopts the crude drug proportioning of Chinese patent medicine of the present invention referring to embodiment 6), take 7 days rear intestinals and led to, and took 30 days, so far not recurrence.
4, Zhao so-and-so, 41 years old, people from Zhengzhou City, the police is diagnosed as hypertension, colitis through hospital, my oral account, sensation gastric acid, flatulence.In May, 2008, come here to go to a doctor upon somebody's introduction, take the Chinese herbal medicine powder that the present invention treats digestive system disease (one day one bag, every bag 15 gram takes after mixing it with hot water and takes; This patient adopts the crude drug proportioning of Chinese patent medicine of the present invention referring to embodiment 8), take 1 month postcolon inflammation, gastric acid, flatulence and eliminate, take hypertension symptom disappearance after 2 months.So far not recurrence.
5, Zhang, the woman, 55 years old, the workman, people from Luoyang City is diagnosed as hypertension, constipation through hospital.I give an oral account: dizziness, dyschesia, abdominal distention.Come here to go to a doctor upon somebody's introduction, take the Chinese herbal medicine powder that the present invention treats digestive system disease (one day one bag, every bag 15 gram takes after mixing it with hot water and takes; This patient adopts the crude drug proportioning of Chinese patent medicine of the present invention referring to embodiment 11), take various transference cures after 1 month, recover normal.
6, Liu, man, 18 years old, people from Xiuwu County, often long on the face comedo, constipation.My oral account: often go out on the face dense, times of defecation is less, and often feels abdominal distention.Come here to go to a doctor upon somebody's introduction, take the Chinese herbal medicine powder that the present invention treats digestive system disease (one day one bag, every bag 15 gram takes after mixing it with hot water and takes; This patient adopts the crude drug proportioning of Chinese patent medicine of the present invention referring to embodiment 16), take various transference cures after 5 days, recover normal.
7, the king so-and-so, the woman, 51 years old, people from Zhengzhou City, often occur after in March, 2005 tripe expand, dizzy, be diagnosed as hypertension, diabetes by hospital.Come here to go to a doctor upon somebody's introduction, take the Chinese herbal medicine powder that the present invention treats digestive system disease (one day one bag, every bag 15 gram takes after mixing it with hot water and takes; This patient adopts the crude drug proportioning of Chinese patent medicine of the present invention referring to embodiment 23), begin to take the bloated disappearance of tripe after 4 days, the stool beginning is normal.After then taking 3 months continuously, normal through the examination in hospital blood pressure.
Four, the specific embodiment:
Following examples only in order to further specify the present invention, do not limit content of the present invention.
Embodiment 1:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 18 parts in the Radix Rehmanniae, 9 parts of Radix Ophiopogonis, 15 parts of Cortex Moutans, 16 parts of Radix Scrophulariaes, 18 parts of 15 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Preparation method is: take by weighing various crude drug according to above-mentioned raw materials medicine proportioning ratio, various crude drug are pulverized, filtered, obtain the medicated powder of various crude drug, the medicated powder with its various crude drug after the pulverizing mixes, and the standard according to every bag of 15g behind the mix homogeneously is carried out packing.
Embodiment 2: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 3 parts in the Radix Rehmanniae, 3 parts of Radix Ophiopogonis, 3 parts of Cortex Moutans, 3 parts of Radix Scrophulariaes, 5 parts of 3 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 3: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 40 parts in the Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 30 parts of Cortex Moutans, 30 parts of Radix Scrophulariaes, 30 parts of 30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 4: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 9 parts in the Radix Rehmanniae, 6 parts of Radix Ophiopogonis, 8 parts of Cortex Moutans, 10 parts of Radix Scrophulariaes, 11 parts of 9 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 5: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 28 parts in the Radix Rehmanniae, 12 parts of Radix Ophiopogonis, 22 parts of Cortex Moutans, 23 parts of Radix Scrophulariaes, 24 parts of 22 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 6: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 36 parts in the Radix Rehmanniae, 14 parts of Radix Ophiopogonis, 26 parts of Cortex Moutans, 28 parts of Radix Scrophulariaes, 28 parts of 27 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 7: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 15 parts in the Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 25 parts of Cortex Moutans, 18 parts of Radix Scrophulariaes, 16 parts of 25 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 8: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 32 parts in the Radix Rehmanniae, 7 parts of Radix Ophiopogonis, 10 parts of Cortex Moutans, 23 parts of Radix Scrophulariaes, 22 parts of 18 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 9: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 15 parts in the Radix Rehmanniae, 8 parts of Radix Ophiopogonis, 10 parts of Cortex Moutans, 10 parts of Radix Scrophulariaes, 15 parts of 10 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 10: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 5 parts in the Radix Rehmanniae, 4 parts of Radix Ophiopogonis, 8 parts of Cortex Moutans, 7 parts of Radix Scrophulariaes, 10 parts of 4 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 11: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 12 parts in the Radix Rehmanniae, 7 parts of Radix Ophiopogonis, 5 parts of Cortex Moutans, 4 parts of Radix Scrophulariaes, 9 parts of 8 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 12: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 8 parts in the Radix Rehmanniae, 6 parts of Radix Ophiopogonis, 4 parts of Cortex Moutans, 9 parts of Radix Scrophulariaes, 12 parts of 7 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 13: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 30 parts in the Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 20 parts of Cortex Moutans, 20 parts of Radix Scrophulariaes, 25 parts of 20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 14: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 26 parts in the Radix Rehmanniae, 8 parts of Radix Ophiopogonis, 12 parts of Cortex Moutans, 16 parts of Radix Scrophulariaes, 20 parts of 13 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 15: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 15 parts in the Radix Rehmanniae, 12 parts of Radix Ophiopogonis, 18 parts of Cortex Moutans, 10 parts of Radix Scrophulariaes, 15 parts of 10 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 16: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 20 parts in the Radix Rehmanniae, 14 parts of Radix Ophiopogonis, 10 parts of Cortex Moutans, 12 parts of Radix Scrophulariaes, 18 parts of 17 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 17: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 30 parts in the Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 20 parts of Cortex Moutans, 20 parts of Radix Scrophulariaes, 25 parts of 20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 18: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 33 parts in the Radix Rehmanniae, 14 parts of Radix Ophiopogonis, 28 parts of Cortex Moutans, 25 parts of Radix Scrophulariaes, 28 parts of 25 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 19: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 40 parts in the Radix Rehmanniae, 12 parts of Radix Ophiopogonis, 30 parts of Cortex Moutans, 28 parts of Radix Scrophulariaes, 30 parts of 23 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 20: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 37 parts in the Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 24 parts of Cortex Moutans, 30 parts of Radix Scrophulariaes, 26 parts of 30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 21: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 3 parts in the Radix Rehmanniae, 3 parts of Radix Ophiopogonis, 3 parts of Cortex Moutans, 10 parts of Radix Scrophulariaes, 15 parts of 10 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 22: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 15 parts in the Radix Rehmanniae, 8 parts of Radix Ophiopogonis, 10 parts of Cortex Moutans, 20 parts of Radix Scrophulariaes, 25 parts of 20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 23: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 9 parts in the Radix Rehmanniae, 6 parts of Radix Ophiopogonis, 7 parts of Cortex Moutans, 15 parts of Radix Scrophulariaes, 20 parts of 15 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 24: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 12 parts in the Radix Rehmanniae, 4 parts of Radix Ophiopogonis, 9 parts of Cortex Moutans, 18 parts of Radix Scrophulariaes, 18 parts of 12 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 25: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 30 parts in the Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 20 parts of Cortex Moutans, 30 parts of Radix Scrophulariaes, 30 parts of 30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 26: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 13 parts in the Radix Rehmanniae, 12 parts of Radix Ophiopogonis, 15 parts of Cortex Moutans, 25 parts of Radix Scrophulariaes, 28 parts of 25 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 27: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 18 parts in the Radix Rehmanniae, 8 parts of Radix Ophiopogonis, 18 parts of Cortex Moutans, 20 parts of Radix Scrophulariaes, 25 parts of 23 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 28: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 15 parts in the Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 10 parts of Cortex Moutans, 26 parts of Radix Scrophulariaes, 27 parts of 20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 29: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 30 parts in the Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 20 parts of Cortex Moutans, 10 parts of Radix Scrophulariaes, 5 parts of 10 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 30: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 40 parts in the Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 30 parts of Cortex Moutans, 20 parts of Radix Scrophulariaes, 15 parts of 20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 31: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 35 parts in the Radix Rehmanniae, 12 parts of Radix Ophiopogonis, 25 parts of Cortex Moutans, 15 parts of Radix Scrophulariaes, 10 parts of 15 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 32: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 32 parts in the Radix Rehmanniae, 14 parts of Radix Ophiopogonis, 28 parts of Cortex Moutans, 12 parts of Radix Scrophulariaes, 12 parts of 18 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 33: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 3 parts in the Radix Rehmanniae, 8 parts of Radix Ophiopogonis, 10 parts of Cortex Moutans, 20 parts of Radix Scrophulariaes, 10 parts of 15 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 34: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 15 parts in the Radix Rehmanniae, 15 parts of Radix Ophiopogonis, 20 parts of Cortex Moutans, 30 parts of Radix Scrophulariaes, 20 parts of 25 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 35: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 9 parts in the Radix Rehmanniae, 12 parts of Radix Ophiopogonis, 15 parts of Cortex Moutans, 25 parts of Radix Scrophulariaes, 15 parts of 20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Embodiment 36: substantially the same manner as Example 1, difference is:
The present invention treats the Chinese patent medicine of digestive system disease, and the raw material of Chinese patent medicine consists of: represent 6 parts in the Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 12 parts of Cortex Moutans, 28 parts of Radix Scrophulariaes, 16 parts of 18 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis with weight portion.
Claims (10)
1. a Chinese patent medicine for the treatment of digestive system disease is characterized in that: represent with weight portion, contain 3～40 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 3～15 parts of Radix Ophiopogonis, 3～30 parts of Cortex Moutans, 3～30 parts of Radix Scrophulariaes, 5～30 parts of 3～30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
2. the Chinese patent medicine of treatment digestive system disease according to claim 1, it is characterized in that: contain 3～15 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 3～8 parts of Radix Ophiopogonis, 3～10 parts of Cortex Moutans, 3～10 parts of Radix Scrophulariaes, 5～15 parts of 3～10 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
3. the Chinese patent medicine of treatment digestive system disease according to claim 1, it is characterized in that: contain 15～30 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 8～15 parts of Radix Ophiopogonis, 10～20 parts of Cortex Moutans, 10～20 parts of Radix Scrophulariaes, 15～25 parts of 10～20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
4. the Chinese patent medicine of treatment digestive system disease according to claim 1, it is characterized in that: contain 30～40 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 10～15 parts of Radix Ophiopogonis, 20～30 parts of Cortex Moutans, 20～30 parts of Radix Scrophulariaes, 25～30 parts of 20～30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
5. the Chinese patent medicine of treatment digestive system disease according to claim 1, it is characterized in that: contain 3～15 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 3～8 parts of Radix Ophiopogonis, 3～10 parts of Cortex Moutans, 10～20 parts of Radix Scrophulariaes, 15～25 parts of 10～20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
6. the Chinese patent medicine of treatment digestive system disease according to claim 1, it is characterized in that: contain 15～30 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 8～15 parts of Radix Ophiopogonis, 10～20 parts of Cortex Moutans, 20～30 parts of Radix Scrophulariaes, 25～30 parts of 20～30 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
7. the Chinese patent medicine of treatment digestive system disease according to claim 1, it is characterized in that: contain 30～40 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 10～15 parts of Radix Ophiopogonis, 20～30 parts of Cortex Moutans, 10～20 parts of Radix Scrophulariaes, 5～15 parts of 10～20 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
8. the Chinese patent medicine of treatment digestive system disease according to claim 1, it is characterized in that: contain 3～15 parts in the crude drug Radix Rehmanniae in the Chinese patent medicine of described treatment digestive system disease, 8～15 parts of Radix Ophiopogonis, 10～20 parts of Cortex Moutans, 20～30 parts of Radix Scrophulariaes, 10～20 parts of 15～25 parts of Radix Salviae Miltiorrhizaes and dried Fructus Crataegis.
9. according to the Chinese patent medicine of each described treatment digestive system disease of claim 1～8, it is characterized in that, the preparation method of the Chinese patent medicine of described treatment digestive system disease is: the crude drug proportioning ratio according to the Chinese patent medicine of each described treatment digestive system disease of claim 1～8 takes by weighing various crude drug, various crude drug are pulverized, filtered, obtain the medicated powder of various crude drug, medicated powder with its various crude drug after the pulverizing mixes, and packs behind the mix homogeneously to get final product.
10. according to the Chinese patent medicine of each described treatment digestive system disease of claim 1～8, it is characterized in that: the dosage form of the Chinese patent medicine of described treatment digestive system disease is pharmaceutically acceptable dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110179236 CN102228616B (en) | 2011-06-29 | 2011-06-29 | Chinese patent medicine for treating digestive system disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110179236 CN102228616B (en) | 2011-06-29 | 2011-06-29 | Chinese patent medicine for treating digestive system disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102228616A true CN102228616A (en) | 2011-11-02 |
| CN102228616B CN102228616B (en) | 2012-12-26 |
Family
ID=44841248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110179236 Expired - Fee Related CN102228616B (en) | 2011-06-29 | 2011-06-29 | Chinese patent medicine for treating digestive system disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228616B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105797003A (en) * | 2016-04-20 | 2016-07-27 | 三株福尔制药有限公司 | Probiotics fermentation traditional Chinese medicine compound composition for treating colorectal cancer and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1325706A (en) * | 2000-05-31 | 2001-12-12 | 王定忠 | Liquid medicine for baby to invigorate function of spleen and promote secretion of body fluid |
| CN101708327A (en) * | 2009-10-27 | 2010-05-19 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating diseases of weakness of spleen and stomach and indigestion and preparation method thereof |
-
2011
- 2011-06-29 CN CN 201110179236 patent/CN102228616B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1325706A (en) * | 2000-05-31 | 2001-12-12 | 王定忠 | Liquid medicine for baby to invigorate function of spleen and promote secretion of body fluid |
| CN101708327A (en) * | 2009-10-27 | 2010-05-19 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating diseases of weakness of spleen and stomach and indigestion and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105797003A (en) * | 2016-04-20 | 2016-07-27 | 三株福尔制药有限公司 | Probiotics fermentation traditional Chinese medicine compound composition for treating colorectal cancer and preparation method and application thereof |
| CN105797003B (en) * | 2016-04-20 | 2019-08-06 | 三株福尔制药有限公司 | A kind of probiotics fermention Traditional Chinese medicine compound composition and its preparation method and application for treating colon cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102228616B (en) | 2012-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101940766B (en) | Medicine for radically curing myocardial infarction and preparation method thereof | |
| CN103550517B (en) | A kind of medicine of Hepatoma therapy | |
| CN103071023B (en) | Traditional Chinese medicinal composition for effectively treating diabetes | |
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN102836409B (en) | Traditional Chinese medicine for treating postpartum lochiorrhea and preparation method | |
| CN103263647B (en) | Traditional Chinese medicine for treating postnatal lochiorrhea and preparation method thereof | |
| CN103007062B (en) | Chinese medicinal preparation for treating cerebral thrombosis | |
| CN104189783A (en) | Traditional Chinese medicine for treating oral ulcer | |
| CN101912551B (en) | Miscarriage-prevention Chinese medicinal composition | |
| CN105535390A (en) | Traditional Chinese medicine decoction for treating coronary heart disease and preparation method of traditional Chinese medicine decoction | |
| CN103751691B (en) | A kind of medicine for the treatment of eczema | |
| CN101095828A (en) | Chinese traditional medicine composition for treating diabetes constipation | |
| CN102988639B (en) | Medicament for treating cervical spondylosis and preparation method of medicament | |
| CN102847074B (en) | Blood stasis removing pill for treating ankylosing spondylitis | |
| CN102293964B (en) | Medicine for treating gastric ulcer, and preparation method thereof | |
| CN102228616B (en) | Chinese patent medicine for treating digestive system disease | |
| CN103735921A (en) | Medicine for treating urethritis and preparation method thereof | |
| CN103550604A (en) | Traditional Chinese medicine for treating neurodermatitis | |
| CN103735950B (en) | A kind of for Chinese medicine composition preventing and treating hemorrhoid and preparation method thereof | |
| CN101130032A (en) | Proprietary Chinese medicine for building up body, qi-benefitting and blood-nourishing after miscarriage or dilatation curettage | |
| CN105056126A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN104398927A (en) | Traditional Chinese medicinal preparation for treating gonarthromeningitis | |
| CN103330760A (en) | Medicament used for treating allergic purpura | |
| CN102872290B (en) | Chinese medicament for treating menstrual disorder | |
| CN105456499A (en) | Traditional Chinese medicine preparation for treating constipation and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20130629 |